State of Cambridge, MA Funding 2026

18 active investors and 11 funded companies in Cambridge, MA. Most active: Wellington Management, Flagship Pioneering, Khosla Ventures.

Cambridge, MA accounts for 120 tracked companies with verified cap-table data, 120 of which disclose round sizes totalling $36B. The median disclosed raise is $196M, and the largest is University of Cambridge at $2.3B, ahead of Cambridge Quantum Computing ($1.7B) and ElevateBio ($1.3B).

The names that recur most often on these cambridge, ma cap tables are Flagship Pioneering (10 companies), RA Capital Management (9 companies), Alexandria Venture Investments (9 companies), Invus (8 companies), GV (8 companies), Third Rock Ventures (8 companies). By latest disclosed round, the market skews Series B (26), Series C (25), Series A (23), IPO (14).

Best funded Cambridge, MA companies

  1. University of Cambridge — $2.3B
  2. Cambridge Quantum Computing — $1.7B (latest: IPO)
  3. ElevateBio — $1.3B (latest: Series D)
  4. Beam Therapeutics — $1B (latest: IPO)
  5. Earendil Labs — $787M (latest: Series B)
  6. Suno — $775M (latest: Series D)
  7. Relay Therapeutics — $732M (latest: Series A)
  8. Moderna Therapeutics — $650M (latest: Series G)
  9. CuspAI — $650M (latest: Seed)
  10. Moderna — $650M (latest: Series G)
  11. Spyre Therapeutics — $644M (latest: Growth)
  12. FerGene — $570M
  13. Hemab — $537M (latest: IPO)
  14. Fog Pharmaceuticals — $506M (latest: Series E)
  15. Valo Health — $500M (latest: Series B)

More Cambridge MA research (1)

Research on comparable markets (18)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library